Work

Development of a huPCLS platform to explore IL-33 biology and test novel therapies

Year: 2023

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2023.pa1853

Authors: Katherine Stephenson, Aoife Kelly, Claire Hollins, Sofia Koch, Tina Baker, Yoichiro Ohne, Jingjing Li, Xavier Romero Ros, Suzanne Cohen, Josquin Nys

Institutions: AstraZeneca (United Kingdom), AstraZeneca (United States)

Language: English

Topic: IL-33, ST2, and ILC Pathways

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387979607

Cites:

Cited by:

Related to: 10